118 related articles for article (PubMed ID: 36400702)
1. Meta-learning algorithm development to predict outcomes in patients with hepatitis C virus-related hepatocellular carcinoma.
Lithy RM; Omar Abdelaziz A; Awad A; Ibrahim Shousha H; Omran D; Mahmoud Nabil M; Hosni Abdelmaksoud A; Mahmoud Elbaz T; Mabrouk M
Arab J Gastroenterol; 2022 Nov; 23(4):230-234. PubMed ID: 36400702
[TBL] [Abstract][Full Text] [Related]
2. Application of data mining techniques to explore predictors of HCC in Egyptian patients with HCV-related chronic liver disease.
Omran DA; Awad AH; Mabrouk MA; Soliman AF; Aziz AO
Asian Pac J Cancer Prev; 2015; 16(1):381-5. PubMed ID: 25640385
[TBL] [Abstract][Full Text] [Related]
3. Data Mining and Machine Learning Algorithms Using IL28B Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C.
Shousha HI; Awad AH; Omran DA; Elnegouly MM; Mabrouk M
Jpn J Infect Dis; 2018 Jan; 71(1):51-57. PubMed ID: 29279441
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning Prediction Models for Diagnosing Hepatocellular Carcinoma with HCV-related Chronic Liver Disease.
Hashem S; ElHefnawi M; Habashy S; El-Adawy M; Esmat G; Elakel W; Abdelazziz AO; Nabeel MM; Abdelmaksoud AH; Elbaz TM; Shousha HI
Comput Methods Programs Biomed; 2020 Nov; 196():105551. PubMed ID: 32580053
[TBL] [Abstract][Full Text] [Related]
5. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
Audureau E; Carrat F; Layese R; Cagnot C; Asselah T; Guyader D; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Chazouillères O; Mallat A; Grangé JD; Attali P; d'Alteroche L; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Pol S; Nahon P;
J Hepatol; 2020 Dec; 73(6):1434-1445. PubMed ID: 32615276
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma Multidisciplinary Clinic-Cairo University (HMC-CU) score: A new simple score for diagnosis of HCC.
Abdelaziz AO; Nabil MM; Omran DA; Abdelmaksoud AH; Asem N; Shousha HI; Elbaz TM; Leithy R
Arab J Gastroenterol; 2020 Jun; 21(2):102-105. PubMed ID: 32439235
[TBL] [Abstract][Full Text] [Related]
7. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis.
Wong GL; Hui VW; Tan Q; Xu J; Lee HW; Yip TC; Yang B; Tse YK; Yin C; Lyu F; Lai JC; Lui GC; Chan HL; Yuen PC; Wong VW
JHEP Rep; 2022 Mar; 4(3):100441. PubMed ID: 35198928
[TBL] [Abstract][Full Text] [Related]
8. Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B-related hepatocellular carcinoma.
Feng G; He N; Xia HH; Mi M; Wang K; Byrne CD; Targher G; Yuan HY; Zhang XL; Zheng MH; Ye F
J Gastroenterol Hepatol; 2022 Nov; 37(11):2145-2153. PubMed ID: 35816347
[TBL] [Abstract][Full Text] [Related]
9. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.
Abdelaziz AO; Shousha HI; Said EM; Soliman ZA; Shehata AA; Nabil MM; Abdelmaksoud AH; Elbaz TM; Abdelsalam FM
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1384-1388. PubMed ID: 30179227
[TBL] [Abstract][Full Text] [Related]
11. Using Quasispecies Patterns of Hepatitis B Virus to Predict Hepatocellular Carcinoma With Deep Sequencing and Machine Learning.
Chen S; Zhang Z; Wang Y; Fang M; Zhou J; Li Y; Dai E; Feng Z; Wang H; Yang Z; Li Y; Huang X; Jia J; Li S; Huang C; Tong L; Xiao X; He Y; Duan Y; Zhu S; Gao C
J Infect Dis; 2021 Jun; 223(11):1887-1896. PubMed ID: 33049037
[TBL] [Abstract][Full Text] [Related]
12. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
[TBL] [Abstract][Full Text] [Related]
13. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
14. Development of novel score based on Angiogenic panel for accurate diagnosis of hepatocellular carcinoma among hepatitis C virus high-risk patients.
Abdelgawad ME; Darwish H; Nabawy MM; El-Mezayen H
Infect Genet Evol; 2020 Nov; 85():104572. PubMed ID: 32987190
[TBL] [Abstract][Full Text] [Related]
15. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
16. HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma.
Omar M; Farid K; Emran T; El-Taweel F; Tabll A; Omran M
Br J Biomed Sci; 2021 Apr; 78(2):72-77. PubMed ID: 33016838
[TBL] [Abstract][Full Text] [Related]
17. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
18. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.
Semmler G; Meyer EL; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Bauer D; Chromy D; Simbrunner B; Scheiner B; Stättermayer AF; Pinter M; Schöfl R; Russo FP; Greenfield H; Schwarz M; Schwarz C; Gschwantler M; Alonso López S; Manzano ML; Ahumada A; Bañares R; Pons M; Rodríguez-Tajes S; Genescà J; Lens S; Trauner M; Ferenci P; Reiberger T; Mandorfer M
J Hepatol; 2022 Apr; 76(4):812-821. PubMed ID: 34871626
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis.
Ioannou GN; Tang W; Beste LA; Tincopa MA; Su GL; Van T; Tapper EB; Singal AG; Zhu J; Waljee AK
JAMA Netw Open; 2020 Sep; 3(9):e2015626. PubMed ID: 32870314
[TBL] [Abstract][Full Text] [Related]
20. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
